Literature DB >> 20532942

Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan.

Hiroshi Sakata1, Yoshitake Sato, Masato Nonoyama, Tsunekazu Haruta, Kazunobu Ouchi, Satoru Yamaguchi, Keisuke Sunakawa.   

Abstract

An evaluation committee was organized to evaluate 464 cases of bacterial meningitis treated at 108 nationwide medical facilities participating in this survey between April 2004 and January 2007. There were 413 evaluable cases of bacterial meningitis, including 342 children (82.8%) and 71 adults (17.2%). Haemophilus influenzae (217 cases, 63.5%) and Streptococcus pneumoniae (35 cases, 49.3%) were the most frequent pathogens for meningitis in children and adults, respectively. The most used initial therapy for children was carbapenem + cephalosporin therapy (212 cases, 61.9%). Of the 333 children included in efficacy evaluation, 320 (96.1%) were rated as remission, 10 (3.0%) as partial remission, and three (0.9%) as poor response. The combination therapy with two drugs was also most often used in adults (41 cases, 57.7%). In efficacy analysis in 60 adults, remission was observed in 50 (83.3%), partial remission in five (8.3%) and poor response in five (8.3%). In prognosis analysis, 273 (80.3%) among 340 children were alive at the end of treatment without sequelae, but one (0.3%) died by the end of treatment, and 64 (18.8%) had sequelae. Of all adults, six (8.5%) died of bacterial meningitis and 23 (32.4%) had sequelae at the end of treatment. Among the patients followed up for 1 year, 26 (12.3%) of 211 children and three (7.7%) of 39 adults had sequelae. The selection of drugs and its dose level of many cases were appropriate, but the dose level of several cases was inappropriate. It is necessary to spread the method of proper antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532942     DOI: 10.1007/s10156-010-0064-6

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.

Authors:  Layla K Mahdi; Hui Wang; Mark B Van der Hoek; James C Paton; Abiodun D Ogunniyi
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

2.  Factors associated with early complications in inpatients who were treated in our clinic between 1992 and 2011 with a diagnosis of acute bacterial meningitis.

Authors:  Meltem Bor; Haluk Çokuğraş
Journal:  Turk Pediatri Ars       Date:  2020-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.